Zobrazeno 1 - 8
of 8
pro vyhledávání: '"NINA KUZMINA"'
Autor:
Maira Espenbetova, Nina Kuzmina, Alexandr Zubkov, Venera Akhmetova, Zhanar Zamanbekova, Ainur Krykpaeva, Zhanar Zhumanbayeva, Kuralay Amrenova, Zhanargul Smailova, Natalya Glushkova
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 27, Iss , Pp 100293- (2022)
Background: Antibodies against thyroid peroxidase (anti-TPO) serve as clinical markers of thyroid autoimmune diseases (TAIDs). By trying to elucidate the causes of heterogeneity in autoantibody levels among patients with different TAIDs it becomes po
Externí odkaz:
https://doaj.org/article/8402d39a69754f2b91888c2d87654376
Publikováno v:
Pediatric Rheumatology Online Journal
Interleukin-1β (IL-1β) is a basic mediator of cryopyrin-associated periodic syndromes (CAPS). In this respect an experience of the use of IL-1 inhibitors has been gained in patients with CAPS. Canakinumab was approved by FDA and EMEA in 2009 and re
Autor:
James T. Cassidy, Nina Kuzmina, Alexei Maximov, Alexander Shaikov, Earl J. Brewer, Edward H. Giannini
Publikováno v:
Seminars in Arthritis and Rheumatism. 23:34-46
Results from three randomized placebo-controlled trials were combined in a meta-analysis to compare the clinical utility of four advanced drug therapy agents used to treat juvenile rheumatoid arthritis (JRA): D-penicillamine (10 mg/kg/d), hydroxychlo
Autor:
Igor Vorontsov, Chester W. Fink, James T. Cassidy, Edward H. Giannini, Arthur J. Newman, Alexei Maximov, Nina Kuzmina, Alexander Shaikov, Lawrence S. Zemel, Earl J. Brewer
Publikováno v:
New England Journal of Medicine. 326:1043-1049
Background. The antimetabolite methotrexate has been shown in placebo-controlled trials to be effective in adults with rheumatoid arthritis. Methotrexate may also be effective in children with resistant juvenile rheumatoid arthritis, but the supporti
Publikováno v:
Arthritis & Rheumatism. 33:466-476
A 6-month double-blind, parallel, randomized, placebo-controlled multicenter trial of auranofin (0.15-0.20 mg/kg/day) was conducted in 231 children with juvenile rheumatoid arthritis (JRA) in the United States and in the Union of Soviet Socialist Rep
Autor:
EUNKYOUNG SEO, YOHAN YOON, KYEONGYEOL KIM, WON-BO SHIM, NINA KUZMINA, KEUM-SOON OH, JONG-OK LEE, JUNGHYUCK SUH, SOO-HYUNG LEE, KEE-HEY CHUNG, DUCK-HWA CHUNG, DONG-SUL KIM
Publikováno v:
Journal of Food Protection; Feb2009, Vol. 72 Issue 2, p436-440, 5p, 4 Charts
Publikováno v:
New England Journal of Medicine. 314:1269-1276
One hundred sixty-two children with severe juvenile rheumatoid arthritis were entered in a randomized, double-blind, placebo-controlled 12-month clinical trial designed to establish the efficacy and safety of two slower-acting antirheumatic drugs, pe
Publikováno v:
Arthritis and rheumatism. 31(1)
A 12-month double-blind, parallel, randomized, placebo-controlled multicenter trial of D-penicillamine and hydroxychloroquine was conducted in 162 children with juvenile rheumatoid arthritis in the United States and in the Union of Soviet Socialist R